Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2025-12-29 @ 12:55 AM
Study NCT ID:
NCT01697592
Status:
COMPLETED
Last Update Posted:
2018-09-10
First Post:
2012-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-28
First Submit QC Date:
None
Study First Post Date:
2012-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-29
Results First Submit QC Date:
None
Results First Post Date:
2015-10-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-08
Last Update Post Date:
2018-09-10
Last Update Post Date Type:
ACTUAL